Tumor rejection by disturbing tumor stroma cell interactions

被引:115
作者
Ibe, S
Qin, ZH
Schüler, T
Preiss, S
Blankenstein, T
机构
[1] Free Univ Berlin, Inst Immunol, D-12200 Berlin, Germany
[2] Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany
关键词
tumor stroma; tumor infiltrating macrophages; IFN-gamma; antiangiogenesis; cyclophosphamid;
D O I
10.1084/jem.194.11.1549
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The stroma of solid tumors is a complex network of different cell types. We analyzed stroma cell interactions in two tumor models during cyclophosphamide (Cy)-induced tumor rejection. In growing tumors, tumor infiltrating macrophages (TIMs) produced interleukin (IL)-10. Beginning 6 h after Cy-treatment T cells in the tumor were inactivated and TIMs switched to interferon (IFN)-gamma production. Both, IL-10 production before and IFN-gamma production after Cy-treatment by TIMs required T cells. With the same kinetics as TIMs started to produce IFN-gamma the tumor vasculature was destroyed which required IFN-gamma receptor expression on host but not tumor cells. These events preceded hemorrhagic necrosis and residual tumor cell elimination by T cells. Together, T cells regulate the function of TIMs and tumor rejection can be induced by disturbing the stroma network.
引用
收藏
页码:1549 / 1559
页数:11
相关论文
共 40 条
[1]  
[Anonymous], 1999, INFLAMMATION BASIC P
[2]  
AWWAD M, 1988, IMMUNOLOGY, V65, P87
[3]   Immunopotentiation with low-dose cyclophosphamide in the active specific immunotherapy of cancer [J].
Bass, KK ;
Mastrangelo, MJ .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 1998, 47 (01) :1-12
[4]   Effects of angiogenesis inhibitors on multistage carcinogenesis in mice [J].
Bergers, G ;
Javaherian, K ;
Lo, KM ;
Folkman, J ;
Hanahan, D .
SCIENCE, 1999, 284 (5415) :808-812
[5]  
Blankenstein T, 1996, REV PHYSIOL BIOCH P, V129, P1
[6]   TUMOR SUPPRESSION AFTER TUMOR-CELL TARGETED TUMOR-NECROSIS-FACTOR-ALPHA GENE-TRANSFER [J].
BLANKENSTEIN, T ;
QIN, ZH ;
UBERLA, K ;
MULLER, W ;
ROSEN, H ;
VOLK, HD ;
DIAMANTSTEIN, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (05) :1047-1052
[7]   REGULATION OF THE MACROPHAGE CONTENT OF NEOPLASMS BY CHEMOATTRACTANTS [J].
BOTTAZZI, B ;
POLENTARUTTI, N ;
ACERO, R ;
BALSARI, A ;
BORASCHI, D ;
GHEZZI, P ;
SALMONA, M ;
MANTOVANI, A .
SCIENCE, 1983, 220 (4593) :210-212
[8]  
Browder T, 2000, CANCER RES, V60, P1878
[9]   ENHANCED IN-VIVO GROWTH AND RESISTANCE TO REJECTION OF TUMOR-CELLS EXPRESSING DOMINANT-NEGATIVE IFN-GAMMA RECEPTORS [J].
DIGHE, AS ;
RICHARDS, E ;
OLD, LJ ;
SCHREIBER, RD .
IMMUNITY, 1994, 1 (06) :447-456
[10]  
DVORAK HF, 1986, NEW ENGL J MED, V315, P1650